CLINICAL_TRIALS
research
· 2018-04-26
Clinical Trial Update: Chidamide in Combination With ART for Reactivation of the Latent HIV-1 Reservoir [Phase 2, Phase 3]
Summary
This clinical trial update reports on a Phase 2/Phase 3 study evaluating chidamide in combination with antiretroviral therapy (ART) to reactivate the latent HIV…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tang-Du Hospital | Conditions: Chronic HIV Infections | Phase 2, Phase 3 | Status: UNKNOWN